Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Is stereotactic radiosurgery a rational treatment option for brain metastases from small cell lung cancer? A retrospective analysis of 70 consecutive patients

Figure 1

Survival results for patients with BM from SCLC treated with SRS. The solid line represents overall survival (OS) probability. The median survival time (MST) was 7.8 months (95% CI: 6.2–12.6). One-and 2-year OS rates after SRS were 43% and 15%, respectively. The dotted line represents the neurological death-free survival (NS) probability adjusted for competing events. The 1-and 2-year NS rates after SRS were 94 and 84%, respectively. Note that the distance between these two lines, NS and OS, represents the cumulative incidence of non-neurological death.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us